Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05483881
Other study ID # BCH Lung 016
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 15, 2022
Est. completion date December 31, 2022

Study information

Verified date July 2022
Source Beijing Children's Hospital
Contact Baoping Xu, MD,PhD
Phone 861059616308
Email xubaopingbch@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators expect to reveal the association between air pollution and childhood respiratory diseases through a multi-center observational study, and summarize the relationship between air pollution and childhood respiratory diseases.


Description:

The investigators will collect the data of outpatient and emergency children in Beijing Children's hospital and other participating hospitals due to respiratory diseases from 2010 to 2021, , collect clinical data and basic information, obtain air pollution data and meteorological monitoring data and perform data processing and statistical analysis,,then analyzes the impact of air pollution on children's respiratory diseases.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000000
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 1 Day to 18 Years
Eligibility Inclusion Criteria: - All children participating in this clinical study must meet all of the following criteria: 1. Age: 0-18 years old, male and female 2. Consultation for respiratory diseases 3. Visit time is between 2010-2021 4. Provide complete personally identifiable information and medical information Exclusion Criteria: - All children with any of the following conditions must be excluded from this study: 1. children who visit hospital don't for respiratory diseases 2. children participating in this clinical study don't provide complete personally identifiable information and medical information 3. Visit time is not between 2010-2021.

Study Design


Locations

Country Name City State
China Baoping Xu Beijing Beijing

Sponsors (16)

Lead Sponsor Collaborator
Beijing Children's Hospital Capital Institute of Pediatrics, China, China-Japan Friendship Hospital, First Affiliated Hospital of Xinjiang Medical University, Guangzhou Women and Children's Medical Center, Jiangxi Province Children's Hospital, Kunming Children's Hospital, Shanxi Provincial Maternity and Children's Hospital, Shenzhen Children's Hospital, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Guangzhou Medical University, The First Affiliated Hospital of Xiamen University, Tianjin Children's Hospital, Wuhan Children's Hospital, Xian Children's Hospital, Xianyang children's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major air pollutant concentrations The air pollutant data comes from the daily air quality data published by the National Environmental Monitoring Center. Calculate the arithmetic average of the daily average concentrations of air pollutants (PM10, PM2.5, SO, NO, CO, etc.) Converted from air pollution index (API). 12 years
Secondary Number of daily visits for respiratory diseases in outpatient and emergency departments The number of daily outpatient visits for respiratory diseases( rhinitis, allergic rhinitis, upper respiratory tract infection, bronchitis and bronchiolitis, bronchiolitis obliterans, pneumonia, asthma , allergic cough, chronic cough, upper airway cough syndrome,etc.) in each hospital participating in this study during the study period. 12 years
See also
  Status Clinical Trial Phase
Withdrawn NCT03376204 - Pain Mechanisms in Patients With Bronchiectasis
Not yet recruiting NCT05902702 - Isotonic Saline for Children With Bronchiolitis N/A
Recruiting NCT05246098 - REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
Completed NCT04467190 - Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
Not yet recruiting NCT05374148 - Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.
Recruiting NCT04502368 - Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
Recruiting NCT05775952 - Airway Remodeling and Rhinovirus in Asthmatics
Active, not recruiting NCT02681848 - What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
Recruiting NCT06002685 - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention N/A
Enrolling by invitation NCT03319446 - Collection of Anonymized Samples N/A
Recruiting NCT04287959 - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow) N/A
Completed NCT05017727 - Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
Completed NCT04607330 - Protein Top-up Acceptability Study for Patients With Increased Protein Needs N/A
Completed NCT03334916 - A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients Phase 4
Completed NCT04649736 - Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients N/A
Completed NCT03661801 - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Enrolling by invitation NCT03322254 - How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Not yet recruiting NCT06026163 - Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress Phase 2/Phase 3
Completed NCT04581096 - Mapping COVID-19 Spread in a Tertiary Hospital